QTTB
Q32 Bio Inc
NASDAQ: QTTB · HEALTHCARE · BIOTECHNOLOGY
$5.60
+1.82% today
Updated 2026-04-30
Market cap
$83.68M
P/E ratio
2.36
P/S ratio
1.56x
EPS (TTM)
$2.42
Dividend yield
—
52W range
$1 – $8
Volume
0.3M
WallStSmart proprietary scores
62
out of 100
Grade: C+
Hold
Investment rating
6.0
Growth
B7.5
Quality
B+9.5
Profitability
A+6.7
Valuation
B6/9
Piotroski F-Score
Moderate
-1.5
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$14.33
+155.89%
12-Month target
$7.26
+29.64%
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy2 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Profit margin 55.50% — above average
+ ROE 125.10% — strong efficiency
+ Debt/equity -0.62x — low leverage
Risks
- Altman Z -1.48 — distress zone
- Negative free cash flow $-6.18M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.65M | $-6.65M | $0.00 | $53.74M | $53.74M |
| Net income | $-42.81M | $-53.74M | $-47.73M | $29.82M | $57.73M |
| EPS | — | — | — | — | $2.42 |
| Free cash flow | $-13.44M | $-18.68M | $-67.79M | $-33.55M | $-6.18M |
| Profit margin | -643.65% | 808.04% | — | 55.49% | 55.50% |
Peer comparison
Smart narrative
Q32 Bio Inc trades at $5.60. representing a P/E of 2.36x trailing earnings. Our Smart Value Score of 62/100 indicates the stock is good. The company scores 6/9 on the Piotroski F-Score. With an Altman Z-Score of -1.48, it sits in the distress. TTM revenue stands at $53.74M. with profit margins at 55.50%.
Frequently asked questions
What is Q32 Bio Inc's stock price?
Q32 Bio Inc (QTTB) trades at $5.60.
Is Q32 Bio Inc overvalued?
Smart Value Score 62/100 (Grade C+, Hold).
What is the price target of Q32 Bio Inc (QTTB)?
The analyst target price is $14.33, representing +155.9% upside from the current price of $5.60.
What is Q32 Bio Inc's revenue?
TTM revenue is $53.74M.
Piotroski F-Score?
6/9 — moderate financial health.
Altman Z-Score?
-1.48 — distress.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio1.56x
ROE125.10%
Beta-1.02
50D MA$5.75
200D MA$3.46
Shares out0.01B
Float0.01B
Short ratio—
Avg volume0.3M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—